✦ LIBER ✦

FTY720-Induced Conversion of Conventional Foxp3−CD4+ T Cells to Foxp3+ Regulatory T Cells in NOD Mice

✍ Scribed by Yun Sun; Wenjing Wang; Bin Shan; Jingfang Di; Linlin Chen; Lingling Ren; Weiping Li; Da-Jin Li; Yi Lin

Book ID: 111270489
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 703 KB
Volume: 66
Category: Article
ISSN: 8755-8920
DOI: 10.1111/j.1600-0897.2011.01010.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CD4+FoxP3+regulatory T-cells in cerebral

CD4+FoxP3+regulatory T-cells in cerebral ischemic stroke

✍ Xuefang Ren; Kozaburo Akiyoshi; Arthur A. Vandenbark; Patricia D. Hurn; Halina O 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 180 KB

CD4+CD25+Foxp3+ regulatory T cells induc

CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation–mediated apoptosis of effector CD4+ T cells

✍ Pandiyan, Pushpa; Zheng, Lixin; Ishihara, Satoru; Reed, Jennifer; Lenardo, Micha 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 861 KB

Sub-optimal CD4+ T-cell activation trigg

Sub-optimal CD4+ T-cell activation triggers autonomous TGF-β-dependent conversion to Foxp3+ regulatory T cells

✍ Vanessa G. Oliveira; Marta Caridade; Ricardo S. Paiva; Jocelyne Demengeot; Luis 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 288 KB

FOXP3 Identifies Regulatory CD25brightCD

FOXP3 Identifies Regulatory CD25brightCD4+ T Cells in Rheumatic Joints

✍ D. Cao; O. Börjesson; P. Larsson; A. Rudin; I. Gunnarsson; L. Klareskog; V. Malm 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 748 KB

The lifestyle of naturally occurring CD4

The lifestyle of naturally occurring CD4+CD25+Foxp3+ regulatory T cells

✍ Ethan M. Shevach; Richard A. DiPaolo; John Andersson; Dong-Mei Zhao; Geoffrey L. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 460 KB

IL-2 induces in vivo suppression by CD4+

IL-2 induces in vivo suppression by CD4+CD25+Foxp3+ regulatory T cells

✍ Susan Brandenburg; Takeshi Takahashi; Maurus de la Rosa; Marko Janke; Gabriele K 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 403 KB

## Abstract Interleukin‐2 (IL‐2) treatment is currently used to enhance T cell‐mediated immune responses against tumors or in viral infections. At the same time, IL‐2 is essential for the peripheral homeostasis of CD4^+^CD25^+^Foxp3^+^ regulatory T cells (Treg). In our study, we show that IL‐2 is a